CRESCENT BIOPHARMA
Live / Applied — Non-final action mailed (as of 08 Oct 2025)
What this means for you
Not registered yet, but its 21 May 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99195270
- Mark type
- Design + words
- Filed
- 21 May 2025
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer; House mark for pharmaceutical products for the treatment of cancer; Biologics in the nature of pharmaceutical preparations for the treatment of cancer; Antibodies for medical purposes, namely, for the treatment of cancer
Owner
- Crescent Biopharma, Inc., Waltham, MA, US
Prosecution history
- 27 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 27 Feb 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 27 Feb 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 19 Nov 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 19 Nov 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 08 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Oct 2025 — NON-FINAL ACTION E-MAILED
- 08 Oct 2025 — NON-FINAL ACTION WRITTEN
- 03 Oct 2025 — ASSIGNED TO EXAMINER
- 27 Sept 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 27 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 May 2025 — APPLICATION FILING RECEIPT MAILED
- 21 May 2025 — NEW APPLICATION ENTERED